Please ensure Javascript is enabled for purposes of website accessibility

Why GoodRx Holdings Stock Went Up More Than 15% in January

By Jon Quast - Feb 4, 2021 at 9:17AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It appears to have benefited from traders bidding up stocks with a lot of short interest.

What happened

Shares of GoodRx Holdings (GDRX -8.20%) went up 15.6% in January, according to data provided by S&P Global Market Intelligence. The company did make a couple of investor presentations during the month and even scored an analyst upgrade. But these events didn't correspond with the stock's biggest moves. From Jan. 21 through Jan. 26, GoodRx stock was up 21%.

So what

GoodRx stock's gains did, however, correspond with a major stock market event. GameStop stock also made its biggest moves during late January. At that time, almost any stock with a lot of short interest received a pronounced boost. This applies to GoodRx stock as well. According to Yahoo! Finance, almost 29% of the stock's float is sold short and it would take more than six trading days for shorts to cover. That's not anywhere close to what GameStop's short interest was, but it's still a lot.

A chalkboard displays a line graph that visualizes dollar signs getting larger over time.

Image source: Getty Images.

GoodRx stock has attracted a lot of bearish sentiment for a variety of reasons. This includes a valuation risk, considering it currently trades at almost 40 times trailing sales. Then there's also the perceived looming threat of Amazon disrupting its business. However, don't count Guggenheim's Vikram Kesavabhotla among the bears. During January, Kesavabhotla started covering GoodRx stock by giving it a buy rating and a price target of $52 per share, according to The Fly. 

Now what

To be sure, GoodRx has a lot to prove when it reports earnings later this month. Management guided for revenue of $148 million, good for 31% year-over-year growth. Given its pricey valuation, I believe it will important to at least hit that number.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

GoodRx Holdings, Inc. Stock Quote
GoodRx Holdings, Inc.
GDRX
$8.17 (-8.20%) $0.73
Amazon.com, Inc. Stock Quote
Amazon.com, Inc.
AMZN
$2,216.21 (-1.98%) $-44.89
GameStop Corp. Stock Quote
GameStop Corp.
GME
$91.80 (-6.70%) $-6.59

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
345%
 
S&P 500 Returns
119%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/17/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.